Tower Research Capital (TRC)’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$234K Sell
8,485
-3,562
-30% -$98.3K 0.01% 1636
2025
Q1
$473K Sell
12,047
-47,981
-80% -$1.88M 0.01% 865
2024
Q4
$2.5M Buy
60,028
+43,364
+260% +$1.8M 0.05% 307
2024
Q3
$1.11M Sell
16,664
-55,429
-77% -$3.7M 0.03% 498
2024
Q2
$8.56M Buy
72,093
+43,763
+154% +$5.2M 0.14% 106
2024
Q1
$3.02M Sell
28,330
-30,636
-52% -$3.26M 0.07% 196
2023
Q4
$5.86M Buy
58,966
+38,132
+183% +$3.79M 0.07% 227
2023
Q3
$2.15M Buy
20,834
+1,210
+6% +$125K 0.07% 291
2023
Q2
$2.38M Buy
19,624
+12,633
+181% +$1.53M 0.08% 192
2023
Q1
$1.07M Sell
6,991
-4,494
-39% -$690K 0.03% 407
2022
Q4
$2.06M Sell
11,485
-66,984
-85% -$12M 0.09% 160
2022
Q3
$9.28M Buy
78,469
+19,772
+34% +$2.34M 0.15% 123
2022
Q2
$8.39M Sell
58,697
-55,552
-49% -$7.94M 0.19% 87
2022
Q1
$19.7M Buy
114,249
+71,508
+167% +$12.3M 0.19% 100
2021
Q4
$10.9M Buy
42,741
+21,125
+98% +$5.37M 0.19% 89
2021
Q3
$8.32M Sell
21,616
-28,240
-57% -$10.9M 0.21% 64
2021
Q2
$11.7M Buy
49,856
+25,898
+108% +$6.09M 0.3% 47
2021
Q1
$3.14M Buy
23,958
+17,979
+301% +$2.35M 0.05% 329
2020
Q4
$624K Sell
5,979
-5,203
-47% -$543K 0.02% 831
2020
Q3
$791K Buy
11,182
+9,989
+837% +$707K 0.01% 1207
2020
Q2
$77K Buy
+1,193
New +$77K ﹤0.01% 2689
2020
Q1
Sell
-10,017
Closed -$196K 3574
2019
Q4
$196K Buy
10,017
+5,491
+121% +$107K 0.02% 598
2019
Q3
$72K Buy
+4,526
New +$72K ﹤0.01% 1544
2019
Q2
Sell
-3,709
Closed -$75K 4056
2019
Q1
$75K Buy
+3,709
New +$75K ﹤0.01% 1565